Betamax Remedies Private Limited, a active private limited company, was established on 22 April 1996 in Chandigarh, Chandigarh, India. Engaging in medical consumables & supplies within the manufacturing sector, it holds CIN: U24239CH1996PTC018058. Registered under ROC Roc Chandigarh. it is unlisted. It has an authorized capital of ₹2.28 Cr and a paid-up capital of ₹2.27 Cr.
It upholds a compliant status. Employing 30 professional, Its leadership includes Sunil Kumar Singh (Additional Director), Parminderjit Singh Toor (Managing Director). Past directors included Anil Sharma, Ashok Gupta, Rajvinderjit Singh. It holds ₹1.10 Cr open charges and ₹1.18 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Scf No. 285, First Floor Motor Market, Maimajra, Chandigarh, Chandigarh, 160101.
U24239CH1996PTC018058
018058
22 April 1996
₹2.28 Cr
₹2.27 Cr
Roc Chandigarh
Unlisted
Active
Explore comprehensive insights into Betamax Remedies Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sunil Kumar Singh | Additional Director | 18 May 2023 | Current |
| Parminderjit Singh Toor | Managing Director | 16 Oct 2006 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 31 Mar 2008 | Past |
| Pramod Abcsdd | Director | 05 Oct 2018 | Past |
| Pramod Abcsdd | Director | 31 Mar 2012 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2012 | Past |
| Pramod Abcsdd | Director | 31 Mar 2012 | Past |
| Pramod Abcsdd | Director | 21 Mar 2014 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Betamax Remedies Private Limited, for the financial year ended 2024, experienced significant reduction in revenue, with a 14.09% decrease. The company also saw a substantial fall in profitability, with a 34.7% decrease in profit. The company's net worth moved up by a moderate rise of 1.65%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2024, Betamax Remedies had a public holding of 27.24%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹11,025,000.00
₹11,826,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 24 Dec 2018 | Hdfc Bank Limited | ₹7.43 M | Open |
| 01 Jul 2009 | Director Of Industries | ₹3.00 M | Open |
| 18 Sep 1996 | Punjab National Bank | ₹0.30 M | Open |
| 18 Sep 1996 | Punjab National Bank | ₹0.30 M | Open |
| 07 May 2007 | State Bank Of India | ₹1.18 Cr | Satisfied |
Explore comprehensive loan charge details -
Betamax Remedies has a workforce of 30 employees as of Mar 31, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Betamax Remedies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Betamax Remedies's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Betamax Remedies Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
The activity Betamax Remedies Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chandigarh. was completed.
Sunil Kumar Singh was appointed as a Additional Director was appointed as a Additional Director on 18 May 2023 & has been associated with this company since 2 years 6 months . was recorded as a recent event.
The activity A charge with Hdfc Bank Limited of Rs. 0.74 Cr registered on 24 Dec 2018 with Charge ID 100231059 was modified on 28 Jan 2019. was completed.
Progress on A charge registered on 07 May 2007 via Charge ID 10054372 with State Bank Of India was fully satisfied on 14 Jan 2019. was documented.
A charge with Hdfc Bank Limited amounted to Rs. 0.74 Cr with Charge ID 100231059 was registered on 24 Dec 2018. was recorded as a recent event.
The CIN of Betamax Remedies Private Limited is U24239CH1996PTC018058.
Betamax Remedies Private Limited is headquartered at Scf No. 285, First Floor Motor Market, Maimajra, Chandigarh, Chandigarh, 160101.
Betamax Remedies Private Limited was incorporated on 22 April 1996.
The current directors of Betamax Remedies Private Limited are
The primary industry of Betamax Remedies Private Limited is Manufacturing.
Betamax Remedies Private Limited is unlisted.
The authorized capital of Betamax Remedies Private Limited is ₹2.28 Cr, and the paid-up capital is ₹2.27 Cr.
The compliance status of Betamax Remedies Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX